Cargando…
Targeting epigenetics in sarcomas through EZH2 inhibition
Soft-tissue sarcomas represent a heterogeneous group of diseases with distinct genetic and clinical features accounting for up to 1% of cancer in adults and 15% of cancer in children. Epithelioid sarcoma is an extremely rare and aggressive tumor affecting young adults that is characterized by loss o...
Autor principal: | Italiano, Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140314/ https://www.ncbi.nlm.nih.gov/pubmed/32264965 http://dx.doi.org/10.1186/s13045-020-00868-4 |
Ejemplares similares
-
New immunotherapy strategies for patients with sarcomas: highlights from the 2023 ASCO annual meeting
por: Roulleaux-Dugage, Matthieu, et al.
Publicado: (2023) -
The Targetable Epigenetic Tumor Protein EZH2 is Enriched in Intraocular Medulloepithelioma
por: Avedschmidt, Sarah E., et al.
Publicado: (2016) -
Targeted Disruption of the EZH2/EED Complex Inhibits EZH2-dependent Cancer
por: Kim, Woojin, et al.
Publicado: (2013) -
Ezh2, a novel target in detection and therapy of breast cancer
por: Pourakbar, Sarah, et al.
Publicado: (2017) -
Aberrant epigenetic regulation in clear cell sarcoma of the kidney featuring distinct DNA hypermethylation and EZH2 overexpression
por: Karlsson, Jenny, et al.
Publicado: (2016)